About Bonraybio Co.
Bonraybio Co. Ltd. is an innovative biotechnology enterprise specializing in comprehensive solutions for male infertility, leveraging AI-powered intelligent reproductive testing platforms. The company focuses on developing high-precision and user-friendly medical instruments and solutions to enhance medical quality globally, particularly in the field of human reproduction. Their core products, marketed under the ‘LensHooke®’ brand, include fully automatic AI sperm quality analysis and testing instruments, advanced sperm DNA fragmentation testing kits, and optimum sperm selectors.
Bonraybio’s technology integrates miniaturized high-pixel optical microscope lenses, tightly integrated software and hardware computing platforms, and AI testing algorithms. This allows for intelligent, automated, and standardized test reports for semen quality, including sperm concentration, motility, morphology, and DNA fragmentation index. Their offerings aim to address the global rise in clinical infertility rates driven by factors such as delayed marriage, increased stress, and modern lifestyles. The company is also expanding into other biotechnology and medical testing fields, with future R&D goals including embryo freezing and thawing technology, and reproductive medicine-related obstetrics, gynecology, urology, and clinical medical testing technologies.
Focus Areas
Business Intelligence
| Technology | AI-powered fully automated optical microscopy analysis technology, integrated software and hardware computing platforms, AI testing algorithms, solid-state dye transfer printing technology, sperm motility selection technology |
What Physicians Need to Know
For physicians, Bonraybio's LensHooke® system offers a user-friendly, fully automated, and high-precision solution for male infertility diagnosis and treatment. The AI-powered analysis provides rapid and comprehensive sperm quality parameters, including concentration, motility, morphology, and DNA fragmentation, which can aid in identifying and treating infertility issues. The ability to generate standardized reports and the integration of various testing and selection tools can streamline clinical workflows and potentially improve the success rates of assisted reproductive technologies (ART).
While specific integration details with Electronic Health Records (EHRs) or other hospital systems are not explicitly detailed, the company emphasizes tightly integrated software and hardware computing platforms and LAN connectivity for file sharing and remote access. This suggests a capability for data exchange, which is crucial for seamless integration into existing healthcare IT infrastructures. Further inquiry into their API capabilities or established partnerships for system integrations would be beneficial.
What the Web Says
Bonraybio Co. appears to be a Taiwan-based company specializing in medical diagnostic equipment, particularly in areas like molecular diagnostics and point-of-care testing. Information regarding extensive public reviews on platforms like G2, Glassdoor, Capterra, or Reddit is limited, suggesting a smaller global footprint or a business-to-business focus with less direct public feedback.
Overall: MixedStrengths
- Specialization in medical diagnostics (e.g., molecular diagnostics, POCT)
- Focus on healthcare technology
- Taiwanese manufacturing base often associated with quality
- Participation in industry events (as per their news section)
Limitations
- Limited public reviews available on major platforms (G2, Glassdoor, Capterra, Reddit)
- Lack of readily accessible employer reviews
- Specific product reviews are not easily found
- Potentially smaller market presence outside of Asia
- Information primarily from their own website, lacking third-party validation
Based on reviews from: Bonraybio Co. official website, General web search (for G2, Glassdoor, Capterra, Reddit reviews - none found)
Last updated: 2026-10-17
Videos
News, demos, and interviews about Bonraybio Co..
Videos load interactively. If none appear, search YouTube for Bonraybio Co. →
Press & Coverage
Frequently Asked Questions
Related Companies
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]
AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]
AI-LabTest is a secure, AI-powered digital health platform designed to help individuals understand their medical lab reports. The platform analyzes uploaded bloodwork or diagnostic results (in PDF, JPG, or TXT formats) and translates complex medical data into clear, personalized summaries. These summaries highlight key findings, potential implications, and practical next steps in patient-friendly language. The […]
Google DeepMind is a British-American artificial intelligence (AI) research laboratory and a subsidiary of Alphabet Inc.. Formed in April 2023 through the merger of DeepMind and Google AI’s Google Brain division, the company focuses on advancing artificial general intelligence (AGI) and developing AI systems for widespread public benefit and scientific discovery. Their work involves an […]
Tempus AI, Inc. is an American health technology company that utilizes data and artificial intelligence to deliver precision medicine services. The company was founded with the mission to bring data-driven precision medicine into routine care, initially focusing on oncology. Tempus has developed a platform that sequences tumor samples and employs AI models to assist physicians […]